Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease.
Williams, Marshall V, Cox, Brandon, Ariza, Maria Eugenia · Pathogens (Basel, Switzerland) · 2016 · DOI
Quick Summary
This review examines how herpesvirus proteins called dUTPases may trigger harmful immune responses in ME/CFS and other diseases. Most adults carry dormant herpesviruses (like Epstein-Barr virus) that can reactivate throughout life. The researchers suggest that proteins released during reactivation may overstimulate the immune system, potentially worsening ME/CFS symptoms and inflammation.
Why It Matters
Understanding whether herpesvirus reactivation and dUTPase-mediated immune dysregulation contributes to ME/CFS pathophysiology could open new diagnostic and therapeutic avenues. This work bridges virology, immunology, and ME/CFS research, suggesting that targeting viral lytic proteins rather than the virus itself might reduce symptom burden and inflammation in affected patients.
Observed Findings
Herpesvirus dUTPases function as PAMPs capable of triggering innate immune activation
DUTPases are produced during viral lytic reactivation rather than latency
These proteins can alter the inflammatory cytokine microenvironment
Epstein-Barr virus dUTPase is implicated in immune dysregulation associated with ME/CFS
Herpesvirus reactivation occurs frequently in patients with certain autoimmune and chronic diseases
Inferred Conclusions
HerpesvirusdUTPases represent a novel class of immunoregulatory proteins whose lytic phase expression may exacerbate chronic disease pathology
The immunopathology of herpesvirus-associated diseases may be driven by viral lytic proteins rather than viral replication alone
Targeting dUTPase-mediated immune dysfunction could represent a therapeutic strategy for ME/CFS and related conditions
Herpesvirus reactivation may perpetuate aberrant immune activation through dUTPase-PAMP signaling
Remaining Questions
What is the frequency and degree of herpesvirus reactivation in ME/CFS patients compared to healthy controls?
What This Study Does Not Prove
This review does not establish that dUTPases are the primary cause of ME/CFS, nor does it provide direct clinical evidence that inhibiting these proteins improves patient outcomes. The proposed mechanisms are supported by indirect evidence and animal models; direct causation in human ME/CFS remains to be demonstrated through prospective clinical studies.